NASDAQ : AHG
Akso Health Group — Key statistics
Healthcare · Medical Distribution · China
Last price 1.26 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.08B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.08B |
| Enterprise Value | 1.08B |
Dates
| Measure | Value |
|---|
| Earnings Date | Jul 23, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | n/a |
| Shares Outstanding | 856.70M |
| Shares Change (YoY) | +153.50% |
| Shares Change (QoQ) | +45.36% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.03% |
| Float | 854.04M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 78.04 |
| Forward PS | n/a |
| PB Ratio | 5.97 |
| P/TBV Ratio | 5.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 78.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 21.77 |
| Quick Ratio | 0.17 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -9.85% |
| Return on Assets (ROA) | -1.24% |
| Return on Invested Capital (ROIC) | -2.18% |
| Return on Capital Employed (ROCE) | -2.21% |
| Weighted Average Cost of Capital (WACC) | -1.28% |
| Revenue Per Employee | $1.15M |
| Profits Per Employee | -$1.56M |
| Employee Count | 12 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 70.92 |
Taxes
| Measure | Value |
|---|
| Income Tax | -1.99M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -1.01 |
| 52-Week Price Change | -20.65% |
| 50-Day Moving Average | 1.02 |
| 200-Day Moving Average | 1.51 |
| Relative Strength Index (RSI) | 53.77 |
| Average Volume (20 Days) | 16,235 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 68,625 |
| Short Previous Month | 18,625 |
| Short % of Shares Out | 0.01% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.25 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 13.83M |
| Gross Profit | -11,315 |
| Operating Income | -4.00M |
| Pretax Income | -20.70M |
| Net Income | -18.67M |
| EBITDA | -1.63M |
| EBIT | -4.00M |
| Loss Per Share | -$0.03 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 170,572 |
| Total Debt | 2.38M |
| Net Cash | -2.21M |
| Net Cash Per Share | -$0.00 |
| Equity (Book Value) | 180.92M |
| Book Value Per Share | 0.21 |
| Working Capital | 180.84M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -12.79M |
| Capital Expenditures | -1,638 |
| Depreciation & Amortization | 2.37M |
| Net Borrowing | 350,000 |
| Free Cash Flow | -12.79M |
| FCF Per Share | -$0.01 |
Margins
| Measure | Value |
|---|
| Gross Margin | -0.08% |
| Operating Margin | -28.92% |
| Pretax Margin | -149.69% |
| Profit Margin | -134.99% |
| EBITDA Margin | -11.77% |
| EBIT Margin | -28.92% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -153.50% |
| Shareholder Yield | -153.50% |
| Earnings Yield | -2.38% |
| FCF Yield | -1.19% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 24, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 56.98 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |